PharmaQuest specialises in providing translation and linguistic validation of patient reported outcome measures resulting from clinical trials conducted globally. The company was founded in 2005 and is based in Oxfordshire, employing seven people. Customers include pharmaceutical companies, clinical research organisations and academia.
PharmaQuest’s latest financial statements for the year ended 31 March 2013 show turnover of £1.4 million and adjusted profit before tax of £600,000. Net assets acquired were less than £100,000.
Andrew Brode, Executive Chairman of RWS said, “We are pleased to have acquired PharmaQuest, whose progress we have monitored for several years. It is an attractive business with excellent margins and good growth prospects in a rapidly expanding, specialist sector.”
UK, Chalfont St Peter, Buckinghamshire & Banbury, Oxfordshire